With current economic pressures and tightening market conditions for pharmaceutical companies, it is more important than ever to arm sales and marketing teams with Next Best Action (NBA) solutions to streamline their engagement with healthcare professionals (HCPs). But what does “best” really mean? Today’s Trends: Data Evolution and the Demand for Personalized Engagement We are […]
Only 52% of surveyed pharma executives say they are successfully optimizing engagement across HCP touchpoints, yet 98% say that it’s important to create and implement an omnichannel strategy. What can we learn from the 52% about how to successfully integrate Next Best Action (NBA) programs in omnichannel strategies? Alan Kalton, Senior Vice President, Global Sales […]
3-part Podcast Series Presented by Eularis with Industry Experts Artificial Intelligence is evolving from being an important strategic investment to a must-have at scale today for pharmaceutical companies. More specifically, much of the pharmaceutical industry is introducing artificial intelligence powered next best action (NBA) to drive proactive business intelligence into commercial execution. NBA, also known […]
Almirall LLC, a global biopharmaceutical company focused on skin health, was founded in Barcelona, Spain, in 1943 and today has offices in 21 countries including the U.S. Its innovative medicines are prescribed for a range of dermatology therapeutic areas, including actinic keratosis, acne, psoriasis, and atopic dermatitis. While an innovator in medicines for the skin, […]
The first time we plug into our clients’ CRM and marketing automation systems, many metaphorically cross their fingers. “Our customers are afraid we’ll go back and say, ‘you have nothing to work with,’” says Aktana’s Product Director Rakan Sleiman in a NEXT Normal March 2022 expert roundtable tackling misconceptions around implementing omnichannel AI. “The reality […]
In our last blog, we introduced you to Contextual Intelligence, a specific blend of advanced technologies—like business logic, machine learning and xAI—and human insight that enables life sciences teams to personalize the customer journey and create more meaningful experiences with HCPs. Today, we’re talking about relevance—the factor that determines whether brand interactions are engaged with […]
From industry pubs to internal strategy discussions, it’s hard to remember a time when AI didn’t dominate the conversation. Whether the focus is on driving HCP engagement, predicting next-best actions or unlocking the full potential of data investments, the message to commercial teams is clear: AI is here to stay, and if you don’t already […]